Bioavailability of Xanthones From Mangosteen
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01425047 |
Recruitment Status :
Completed
First Posted : August 29, 2011
Last Update Posted : September 2, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Healthy Volunteers |
Garcinia mangostana L. (mangosteen) is a tropical tree native to Southeast Asia. The pericarp of mangosteen fruit is used in traditional medicine to treat inflammation, infections, wounds, and diarrhea. The proposed health-promoting effects have been attributed to a family of polyphenols referred to as xanthones. Since its introduction into the United States, juices and products containing mangosteen fruit have become a top-selling botanical dietary supplement. This commercial success largely has been the result of aggressive marketing of health claims based on in vitro observations and anecdotal reports.
The purpose of this study was to determine the bioavailability of xanthones from mangosteen juice in adult human subjects. After an overnight fast of at least 10h, male and female subjects were admitted to the Ohio State University Clinical Research Center. Volunteers ingested 2 ounces of 100% mangosteen juice as part of a western-style breakfast. Pericarp particles accounted for 1% of the mass and 99% of total xanthone content in the juice. This dose provided 130 ± 2 mg total xanthones. Blood was collected prior to breakfast and 1,2,3,4,6,8 and 24h. Subjects were fed a mangosteen-free lunch and released from the unit after the 8h collection, refraining from mangosteen containing products until final collection of blood at 24h. Urine was collected for the 24 test period.
Study Type : | Observational |
Actual Enrollment : | 10 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Bioavailability and Anti-inflammatory Activities of Mangostins: a Pilot Study |
Study Start Date : | November 2010 |
Actual Primary Completion Date : | November 2010 |
Actual Study Completion Date : | February 2011 |
Group/Cohort |
---|
Females ingesting mangosteen juice |
Males ingesting mangosteen juice |
- Xanthones in urine [ Time Frame: 0-24 hours ]Urine was collected prior to ingesting mangosteen juice with breakfast and then from consumpotion of juice until 24h.
- Xanthones in sera [ Time Frame: 0-24 hours ]Blood was collected prior to breakfast, and 1, 2, 3, 4, 6, 8 and 24 hours
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- 5 female
- 5 male
- body mass index </= 30
- normal renal function
- non-smoking
Exclusion Criteria:
- smokers
- acute or chronic diseases
- history of gastrointestinal diseases
- >/= 10% weight loss
- dietary or herbal supplement within 6 months of study
- pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01425047
United States, Ohio | |
The Ohio State University, Clinical Research Center | |
Columbus, Ohio, United States, 43210 |
Principal Investigator: | Mark Failla, PhD | Ohio State University |
Responsible Party: | Mark Failla, Professor, Human Nutrition, Associate Dean for Research, Ohio State University |
ClinicalTrials.gov Identifier: | NCT01425047 |
Other Study ID Numbers: |
2010H0219 |
First Posted: | August 29, 2011 Key Record Dates |
Last Update Posted: | September 2, 2011 |
Last Verified: | August 2011 |
mangosteen xanthones dietary supplement |
botanical supplement bioavailability Determine bioavailability of mangosteen xanthones in adults |